News

A new analysis by Global Health 50/50, an initiative to advance gender equality in global health, sheds light on sex disparities in COVID-19 deaths.

The Department of Health and Human Services announced the new option of saliva tests at federal community-based testing sites in areas experiencing COVID-19 surge.

Jim Skogsbergh, president and CEO of Advocate Aurora Health, will join AHA Board Chair Melinda Estes, M.D., Oct. 22 at 3:30 p.m. ET to discuss COVID-19’s impact on health trends and key strategies for reimagining and innovating care during and beyond the pandemic.

COVID-19 is a pandemic with no precedent, and certainly no equal. In many ways, we’ve been learning as we go. For health care professionals, this has elevated the importance of peer-to-peer sharing as never before.

The Department of Health and Human Services announced a pair of innovation challenges aimed at improving maternal and infant health.

Access to potentially life-saving mammograms is more difficult for women who face social determinants of health such as low-income, lack of transportation or the inability to take time off from work.

The Centers for Medicare & Medicaid Services announced Georgia can move forward with a limited Medicaid expansion plan under which enrollees up to 100% of the federal poverty level must comply with, and report, work or other qualifying activities.

A recent article on hospital field finances ignores the diverse experiences of hospitals during the pandemic, particularly those under significant financial pressure, writes Aaron Wesolowski, AHA’s vice president of policy research, analytics and strategy.

The National Institutes of Health announced the start of an adaptive phase 3 clinical trial to evaluate the safety and efficacy of three immune modulator drugs in hospitalized adults with COVID-19.

The Food and Drug Administration Oct. 15 said it reissued its emergency use authorization for certain, Chinese-manufactured filtering face-piece respirators that lack National Institute for Occupational Safety and Health approval.

The Food and Drug Administration Oct. 15 removed epinephrine from the lists of drugs authorized for temporary compounding during the COVID-19 public health emergency by outsourcing facilities and state-licensed pharmacies or federal facilities not registered as outsourcing facilities.

The Centers for Medicare & Medicaid Services Oct. 15 said it will incentivize labs to deliver quicker results to patients undergoing COVID-19 diagnostic testing.

The Department of Health and Human Services announced agreements with CVS and Walgreens to provide and administer COVID-19 vaccines to long-term care facility residents.

Hospitals and health systems have reinvented themselves in many ways to respond to COVID-19. Since March, decades of standard operating procedures have been reexamined, redesigned and refined — all with the goal of saving lives while protecting caregivers and patients’ families during the pandemic.

The AHA Oct. 21 at noon ET will host a webinar featuring leaders from Henry Ford Health System, Ascension Wisconsin and Loyola University Chicago’s Stritch School of Medicine discussing their approaches to addressing community and population health as the field moves from pandemic response to recovery to rebuilding.

A federal appeals court in Washington, D.C., heard oral argument in an appeal from the AHA and hospital groups to overturn a Department of Health and Human Services rule requiring hospitals to disclose their confidential privately negotiated charges with insurers.

The AHA’s American Society for Health Care Engineering Oct. 7 awarded its 2020 Energy Champion Award for outstanding leadership in energy efficiency to The Atrium Health Cleveland in Shelby, N.C.

A new study published Oct. 14 in JAMA Cardiology is highlighting flaws in the Centers for Medicare & Medicaid Services’ Hospital Readmission Reduction Program that resulted in inappropriate penalties on hospitals or, in some cases, overlooking hospitals that should have been penalized.

The Food and Drug Administration Oct. 14 approved Inmazeb for treating Zaire ebolavirus infection in adult and pediatric patients.

In part three of a Value Rounds series on working toward value together, leaders from Northwell Health and Atrium Health's Carolinas Medical Center discuss the role of health care providers — from the front lines to leadership — in improving outcomes, enhancing the patient experience and reducing cost. Robyn Begley, AHA senior vice president and chief nursing officer and CEO of American Organization for Nursing Leadership, moderated the podcast.